Aminoguanidine
|
| |||
| Names | |||
|---|---|---|---|
| IUPAC name
2-Aminoguanidine | |||
Other names
| |||
| Identifiers | |||
3D model (JSmol) |
|||
| ChEMBL | |||
| ChemSpider | |||
| ECHA InfoCard | 100.001.076 | ||
| KEGG | |||
PubChem CID |
|||
| UNII | |||
CompTox Dashboard (EPA) |
|||
| |||
| |||
| Properties | |||
| CH6N4 | |||
| Molar mass | 74.087 g·mol−1 | ||
| Appearance | Crystals | ||
| Density | 1.72 g/cm3 | ||
| Melting point | 206 °C (403 °F; 479 K) Decomposes | ||
| Very soluble | |||
| Solubility in Ethanol | Very soluble | ||
| Related compounds | |||
Related compounds |
|||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |||
Aminoguanidine is the chemical compound with the formula NH2C(=NH)NHNH2. It is a versatile synthetic intermediate.
Aminoguanidine was studied as an investigational drug for the treatment of diabetic nephropathy, under the nonproprietary name Pimagedine, but never left the clinical trial phase due to side effects.